CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Claus Risk Assessment Model for Patients Eligible for Routine Breast Cancer Screening

Last updated: February 18, 2021
Project Number: RB1547-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical utility of the Claus risk assessment model compared with other breast cancer screening models?
  2. What are the evidence-based guidelines regarding the use of breast cancer risk models in determining mammography screening intervals for individuals eligible for routine breast cancer screening?

Key Message

No relevant literature was identified regarding the clinical utility of the Claus risk assessment model compared with other breast cancer screening models. No relevant evidence-based guidelines were identified regarding the use of breast cancer risk models in determining mammography screening intervals for individuals eligible for routine breast cancer screening.